Medicure Inc. (OTCMKTS:MCUJF)’s share price crossed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $3.27 and traded as low as $3.07. Medicure shares last traded at $3.07, with a volume of 200 shares trading hands.
The business has a 50-day moving average of $3.27 and a 200 day moving average of $3.80.
Medicure (OTCMKTS:MCUJF) last issued its quarterly earnings data on Thursday, August 8th. The company reported ($0.04) EPS for the quarter. The company had revenue of $4.71 million for the quarter. Medicure had a negative return on equity of 3.37% and a negative net margin of 10.31%.
Medicure Inc, a cardiovascular pharmaceutical company, engages in the research, clinical development, and commercialization of human therapeutics in Canada, the United States, and Barbados. The company primarily markets and sells AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction, as well as AGGRASTAT high-dose bolus regimen for the reduction of thrombotic cardiovascular events in patients with non ST elevated acute coronary syndrome.
Featured Story: What member countries make up the G-20?
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.